Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis

Patrick Reardon, Michael Zhong, Dana Horakova, Allan G Kermode, Marzena Fabis-Pedrini, Marta Vachova, Julie Prevost, Jeannette Lechner-Scott, Anneke van der Walt, Zbysek Pavelek, Pavel Stourac, Ivana Stetkarova, Jose E Meca-Lallana, Pamela McCombe, Katrin Gross-Paju, Jorge Millan-Pascual, Tomas Kalincik, Izanne Roos, Emmanuelle Lapointe, Jana Houskova, Eva Recmanova, Marek Peterka, Radek Ampapa, Gregor Brecl Jakob, Matteo Foschi, Vilija Jokubaitis, Helmut Butzkueven

Open source

DOI: 10.1016/j.msard.2026.107981
Published: 2026-11
Container: Multiple Sclerosis and Related Disorders
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107981,
  title = {Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis},
  author = {Patrick Reardon and Michael Zhong and Dana Horakova and Allan G Kermode and Marzena Fabis-Pedrini and Marta Vachova and Julie Prevost and Jeannette Lechner-Scott and Anneke van der Walt and Zbysek Pavelek and Pavel Stourac and Ivana Stetkarova and Jose E Meca-Lallana and Pamela McCombe and Katrin Gross-Paju and Jorge Millan-Pascual and Tomas Kalincik and Izanne Roos and Emmanuelle Lapointe and Jana Houskova and Eva Recmanova and Marek Peterka and Radek Ampapa and Gregor Brecl Jakob and Matteo Foschi and Vilija Jokubaitis and Helmut Butzkueven},
  year = {2026},
  journal = {Multiple Sclerosis and Related Disorders},
  doi = {10.1016/j.msard.2026.107981},
  url = {https://doi.org/10.1016/j.msard.2026.107981}
}

RIS

TY  - JOUR
TI  - Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis
AU  - Patrick Reardon
AU  - Michael Zhong
AU  - Dana Horakova
AU  - Allan G Kermode
AU  - Marzena Fabis-Pedrini
AU  - Marta Vachova
AU  - Julie Prevost
AU  - Jeannette Lechner-Scott
AU  - Anneke van der Walt
AU  - Zbysek Pavelek
AU  - Pavel Stourac
AU  - Ivana Stetkarova
AU  - Jose E Meca-Lallana
AU  - Pamela McCombe
AU  - Katrin Gross-Paju
AU  - Jorge Millan-Pascual
AU  - Tomas Kalincik
AU  - Izanne Roos
AU  - Emmanuelle Lapointe
AU  - Jana Houskova
AU  - Eva Recmanova
AU  - Marek Peterka
AU  - Radek Ampapa
AU  - Gregor Brecl Jakob
AU  - Matteo Foschi
AU  - Vilija Jokubaitis
AU  - Helmut Butzkueven
PY  - 2026
JO  - Multiple Sclerosis and Related Disorders
DO  - 10.1016/j.msard.2026.107981
UR  - https://doi.org/10.1016/j.msard.2026.107981
ER  -

APA

Reardon, P., Zhong, M., Horakova, D., Kermode, A. G., Fabis-Pedrini, M., Vachova, M., Prevost, J., Lechner-Scott, J., Walt, A. V. D., Pavelek, Z., Stourac, P., Stetkarova, I., Meca-Lallana, J. E., McCombe, P., Gross-Paju, K., Millan-Pascual, J., Kalincik, T., Roos, I., Lapointe, E., Houskova, J., Recmanova, E., Peterka, M., Ampapa, R., Jakob, G. B., Foschi, M., Jokubaitis, V., & Butzkueven, H. (2026). Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2026.107981

Source records

crossref · retrieved 2026-11-04T06:06:48.879Z